Supernus Pharmaceuticals, Inc. revenue breakdown overview

Supernus Pharmaceuticals, Inc. revenue for the last year amounted to 607.52 M USD, the most of which — 607.52 M USD — came from its highest performing source at the moment, Treatment of Central Nervous System Diseases, the year earlier bringing 667.24 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Supernus Pharmaceuticals, Inc. 607.52 M USD, and the year before that — 667.24 M USD.